nodes	percent_of_prediction	percent_of_DWPC	metapath
Tyloxapol—LPL—SREBP signalling—RNF139—kidney cancer	0.0819	0.112	CbGpPWpGaD
Tyloxapol—LPL—nephron tubule—kidney cancer	0.0602	0.224	CbGeAlD
Tyloxapol—LPL—renal system—kidney cancer	0.0548	0.204	CbGeAlD
Tyloxapol—LPL—kidney—kidney cancer	0.0529	0.197	CbGeAlD
Tyloxapol—LPL—cortex of kidney—kidney cancer	0.0516	0.192	CbGeAlD
Tyloxapol—LPL—cardiac atrium—kidney cancer	0.049	0.183	CbGeAlD
Tyloxapol—LPL—Retinoid metabolism and transport—GPC3—kidney cancer	0.0432	0.0591	CbGpPWpGaD
Tyloxapol—LPL—Vitamin A and Carotenoid Metabolism—ALDH1A1—kidney cancer	0.0376	0.0514	CbGpPWpGaD
Tyloxapol—LPL—Statin Pathway—SCARB1—kidney cancer	0.0287	0.0392	CbGpPWpGaD
Tyloxapol—LPL—Lipoprotein metabolism—SCARB1—kidney cancer	0.0279	0.0382	CbGpPWpGaD
Tyloxapol—LPL—Vitamin A and Carotenoid Metabolism—CRABP1—kidney cancer	0.0261	0.0356	CbGpPWpGaD
Tyloxapol—LPL—Diseases associated with visual transduction—GPC3—kidney cancer	0.0221	0.0302	CbGpPWpGaD
Tyloxapol—LPL—Vitamin A and Carotenoid Metabolism—SCARB1—kidney cancer	0.0209	0.0286	CbGpPWpGaD
Tyloxapol—LPL—Lipid and lipoprotein metabolism—SCARB1—kidney cancer	0.0185	0.0254	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—MME—kidney cancer	0.0177	0.0242	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—APAF1—kidney cancer	0.0165	0.0225	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—HNF1A—kidney cancer	0.0155	0.0212	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—EPAS1—kidney cancer	0.0155	0.0212	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—ITPR2—kidney cancer	0.0149	0.0204	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—SCARB1—kidney cancer	0.0143	0.0196	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—CYP1A1—kidney cancer	0.0126	0.0173	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—UNC5C—kidney cancer	0.00891	0.0122	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—RAF1—kidney cancer	0.00777	0.0106	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—RELA—kidney cancer	0.00774	0.0106	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—PTGS2—kidney cancer	0.00752	0.0103	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—CDKN1B—kidney cancer	0.00712	0.00974	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—SPTBN4—kidney cancer	0.00675	0.00923	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—L1CAM—kidney cancer	0.00675	0.00923	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.00603	0.00824	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—VEGFA—kidney cancer	0.00592	0.0081	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—CER1—kidney cancer	0.0059	0.00807	CbGpPWpGaD
Tyloxapol—LPL—Vitamin A and Carotenoid Metabolism—MAPK1—kidney cancer	0.00563	0.00769	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—MTOR—kidney cancer	0.00549	0.0075	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—MYC—kidney cancer	0.00545	0.00745	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—EPAS1—kidney cancer	0.00534	0.00729	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—HNF1A—kidney cancer	0.00534	0.00729	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	0.00533	0.00729	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—RELA—kidney cancer	0.00513	0.00701	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	0.00504	0.00689	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—HIF1A—kidney cancer	0.0049	0.0067	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—HNF1B—kidney cancer	0.00435	0.00595	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ACY1—kidney cancer	0.00387	0.00529	CbGpPWpGaD
Tyloxapol—LPL—Disease—CCBL1—kidney cancer	0.0037	0.00505	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—MAPK3—kidney cancer	0.00364	0.00497	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—MAPK1—kidney cancer	0.00346	0.00473	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—PIK3CA—kidney cancer	0.00335	0.00457	CbGpPWpGaD
Tyloxapol—LPL—Disease—AMER1—kidney cancer	0.00334	0.00457	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.0033	0.00452	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PDHB—kidney cancer	0.00329	0.0045	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—OR4C13—kidney cancer	0.00324	0.00443	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—CTNNA1—kidney cancer	0.00312	0.00426	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CCBL1—kidney cancer	0.0031	0.00423	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—PAX6—kidney cancer	0.00298	0.00408	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—CTNNB1—kidney cancer	0.00293	0.00401	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—TP53—kidney cancer	0.0029	0.00397	CbGpPWpGaD
Tyloxapol—LPL—Disease—GPC3—kidney cancer	0.0028	0.00383	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.0028	0.00383	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—LATS1—kidney cancer	0.00275	0.00376	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GLIPR1—kidney cancer	0.00268	0.00367	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PPAT—kidney cancer	0.00268	0.00367	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	0.00265	0.00362	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	0.00262	0.00359	CbGpPWpGaD
Tyloxapol—LPL—Disease—ST3GAL2—kidney cancer	0.00259	0.00354	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—PAK1—kidney cancer	0.00259	0.00354	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—APRT—kidney cancer	0.0025	0.00341	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—FH—kidney cancer	0.0025	0.00341	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	0.00244	0.00333	CbGpPWpGaD
Tyloxapol—LPL—Disease—PGK1—kidney cancer	0.00243	0.00332	CbGpPWpGaD
Tyloxapol—LPL—Disease—SLC5A3—kidney cancer	0.00243	0.00332	CbGpPWpGaD
Tyloxapol—LPL—Disease—LDHB—kidney cancer	0.00238	0.00326	CbGpPWpGaD
Tyloxapol—LPL—Disease—SFRP2—kidney cancer	0.00238	0.00326	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GPC3—kidney cancer	0.00235	0.00321	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AMER1—kidney cancer	0.00234	0.0032	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CA2—kidney cancer	0.00228	0.00312	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ALAD—kidney cancer	0.00222	0.00304	CbGpPWpGaD
Tyloxapol—LPL—Disease—TCEB1—kidney cancer	0.00222	0.00304	CbGpPWpGaD
Tyloxapol—LPL—Disease—TCEB2—kidney cancer	0.00222	0.00304	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ST3GAL2—kidney cancer	0.00217	0.00297	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ALDH1A1—kidney cancer	0.00212	0.0029	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PGK1—kidney cancer	0.00203	0.00278	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SLC5A3—kidney cancer	0.00203	0.00278	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—LDHB—kidney cancer	0.002	0.00273	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GPC3—kidney cancer	0.00196	0.00268	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CER1—kidney cancer	0.00196	0.00268	CbGpPWpGaD
Tyloxapol—LPL—Disease—RPL14—kidney cancer	0.00181	0.00247	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CA9—kidney cancer	0.00173	0.00237	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	0.00169	0.00231	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SFRP2—kidney cancer	0.00167	0.00228	CbGpPWpGaD
Tyloxapol—LPL—Disease—ITPR2—kidney cancer	0.00163	0.00223	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—KDR—kidney cancer	0.00161	0.0022	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MET—kidney cancer	0.00158	0.00215	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CRABP1—kidney cancer	0.00147	0.00201	CbGpPWpGaD
Tyloxapol—LPL—Disease—PSMD7—kidney cancer	0.00137	0.00187	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ITPR2—kidney cancer	0.00137	0.00187	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CASP2—kidney cancer	0.00134	0.00184	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AKAP13—kidney cancer	0.00134	0.00184	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—POMC—kidney cancer	0.00126	0.00172	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTT1—kidney cancer	0.00125	0.0017	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ACHE—kidney cancer	0.00125	0.0017	CbGpPWpGaD
Tyloxapol—LPL—Disease—SLC2A1—kidney cancer	0.00124	0.00169	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GRB7—kidney cancer	0.00123	0.00168	CbGpPWpGaD
Tyloxapol—LPL—Disease—JUNB—kidney cancer	0.00123	0.00168	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SCARB1—kidney cancer	0.00118	0.00161	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PTGS1—kidney cancer	0.00117	0.0016	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—RAF1—kidney cancer	0.00116	0.00159	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—RELA—kidney cancer	0.00116	0.00158	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—ERBB2—kidney cancer	0.00115	0.00157	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PSMD7—kidney cancer	0.00115	0.00157	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ITPR2—kidney cancer	0.00114	0.00156	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—BCHE—kidney cancer	0.00109	0.00149	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SLC5A5—kidney cancer	0.00107	0.00147	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CTNNA1—kidney cancer	0.00104	0.00142	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SLC2A1—kidney cancer	0.00104	0.00142	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HSPB1—kidney cancer	0.00103	0.00141	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EIF4EBP1—kidney cancer	0.00103	0.00141	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—CTNNB1—kidney cancer	0.00101	0.00138	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	0.00101	0.00137	CbGpPWpGaD
Tyloxapol—LPL—Disease—CDKN2B—kidney cancer	0.001	0.00137	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PSMD7—kidney cancer	0.000958	0.00131	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ANXA1—kidney cancer	0.000958	0.00131	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TSC1—kidney cancer	0.000958	0.00131	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FLT1—kidney cancer	0.000928	0.00127	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—VEGFA—kidney cancer	0.000887	0.00121	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	0.000877	0.0012	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTP1—kidney cancer	0.000864	0.00118	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—JUNB—kidney cancer	0.00086	0.00118	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PAK1—kidney cancer	0.00086	0.00118	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MAPK3—kidney cancer	0.000839	0.00115	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ABCB1—kidney cancer	0.000818	0.00112	CbGpPWpGaD
Tyloxapol—LPL—Disease—HIF1A—kidney cancer	0.000799	0.00109	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MAPK1—kidney cancer	0.000798	0.00109	CbGpPWpGaD
Tyloxapol—LPL—Disease—TSC2—kidney cancer	0.000797	0.00109	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTM1—kidney cancer	0.000794	0.00109	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—KRAS—kidney cancer	0.000754	0.00103	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP1A1—kidney cancer	0.000753	0.00103	CbGpPWpGaD
Tyloxapol—LPL—Disease—APC—kidney cancer	0.000704	0.000963	CbGpPWpGaD
Tyloxapol—LPL—Disease—KIT—kidney cancer	0.000704	0.000963	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IGF2—kidney cancer	0.000703	0.000961	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CDKN2B—kidney cancer	0.0007	0.000957	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IGF1R—kidney cancer	0.00068	0.00093	CbGpPWpGaD
Tyloxapol—LPL—Disease—BRAF—kidney cancer	0.000662	0.000905	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	0.000619	0.000846	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—POMC—kidney cancer	0.000561	0.000768	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HIF1A—kidney cancer	0.00056	0.000765	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TSC2—kidney cancer	0.000558	0.000763	CbGpPWpGaD
Tyloxapol—LPL—Disease—RAF1—kidney cancer	0.000553	0.000756	CbGpPWpGaD
Tyloxapol—LPL—Disease—ERBB2—kidney cancer	0.000547	0.000748	CbGpPWpGaD
Tyloxapol—LPL—Disease—MTOR—kidney cancer	0.00054	0.000738	CbGpPWpGaD
Tyloxapol—LPL—Disease—CD4—kidney cancer	0.000539	0.000736	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—KDR—kidney cancer	0.000535	0.000732	CbGpPWpGaD
Tyloxapol—LPL—Disease—PTGS2—kidney cancer	0.000535	0.000731	CbGpPWpGaD
Tyloxapol—LPL—Disease—CDKN1B—kidney cancer	0.000506	0.000692	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—APC—kidney cancer	0.000493	0.000674	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—KIT—kidney cancer	0.000493	0.000674	CbGpPWpGaD
Tyloxapol—LPL—Disease—CTNNB1—kidney cancer	0.000478	0.000654	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—POMC—kidney cancer	0.000469	0.000642	CbGpPWpGaD
Tyloxapol—LPL—Disease—PTEN—kidney cancer	0.000466	0.000638	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—BRAF—kidney cancer	0.000464	0.000634	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PTGS2—kidney cancer	0.000448	0.000612	CbGpPWpGaD
Tyloxapol—LPL—Disease—MAPK3—kidney cancer	0.000398	0.000545	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PTEN—kidney cancer	0.000391	0.000534	CbGpPWpGaD
Tyloxapol—LPL—Disease—MYC—kidney cancer	0.000388	0.00053	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—RAF1—kidney cancer	0.000387	0.000529	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—RELA—kidney cancer	0.000385	0.000527	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ERBB2—kidney cancer	0.000383	0.000524	CbGpPWpGaD
Tyloxapol—LPL—Disease—MAPK1—kidney cancer	0.000379	0.000518	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MTOR—kidney cancer	0.000378	0.000517	CbGpPWpGaD
Tyloxapol—LPL—Disease—KRAS—kidney cancer	0.000358	0.00049	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CDKN1B—kidney cancer	0.000355	0.000485	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IL2—kidney cancer	0.000347	0.000474	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCND1—kidney cancer	0.000338	0.000463	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—JUN—kidney cancer	0.000338	0.000462	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CTNNB1—kidney cancer	0.000335	0.000458	CbGpPWpGaD
Tyloxapol—LPL—Disease—PIK3CA—kidney cancer	0.000329	0.00045	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PTEN—kidney cancer	0.000327	0.000446	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—VEGFA—kidney cancer	0.000295	0.000403	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MAPK3—kidney cancer	0.000279	0.000381	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3CA—kidney cancer	0.000275	0.000377	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MYC—kidney cancer	0.000271	0.000371	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MAPK1—kidney cancer	0.000265	0.000363	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—KRAS—kidney cancer	0.000251	0.000343	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3CA—kidney cancer	0.00023	0.000315	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TP53—kidney cancer	0.000223	0.000305	CbGpPWpGaD
